Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eri Samukawa"'
Autor:
Koji Fujita, Hisakazu Iwama, Kyoko Oura, Tomoko Tadokoro, Eri Samukawa, Teppei Sakamoto, Takako Nomura, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Takashi Himoto, Mitsuomi Hirashima, Tsutomu Masaki
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 1, p 74 (2017)
Dysregulation of apoptosis is a major hallmark in cancer biology that might equip tumors with a higher malignant potential and chemoresistance. The anti-cancer activities of lectin, defined as a carbohydrate-binding protein that is not an enzyme or a
Externí odkaz:
https://doaj.org/article/96d63aa9ee8f44aab3bef95210a149ef
Autor:
Tsutomu Masaki, Yoshimi Yamana, Shintaro Fujihara, Hideki Kobara, Kyoko Oura, Eri Samukawa, Taiga Chiyo, Megumi Okamura, Hiroki Yamana, Tomoko Tadokoro, Koji Fujita, Asahiro Morishita, Hisakazu Iwama
Publikováno v:
Journal of cancer research and therapeutics. 18
Pancreatic ductal adenocarcinoma (PDAC) is the most devastating of all cancers with an extremely poor prognosis. It has few effective and reliable therapeutic strategies. Telmisartan, a widely used antihypertensive drug, is an angiotensin II type 1 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd34dbe4b6bd81c6d2a2a4a9a2189e5
https://pubmed.ncbi.nlm.nih.gov/36510981
https://pubmed.ncbi.nlm.nih.gov/36510981
Autor:
Kiyoyuki Kobayashi, Yasuyuki Suzuki, Keiichi Okano, Tomoko Tadokoro, Shintaro Fujihara, Tsutomu Masaki, Eri Samukawa, Asahiro Morishita, Takashi Himoto, Yoshimi Yamana, Hisakazu Iwama, Hirohito Mori, Kyoko Oura, Mai Nakahara, Taiga Chiyo, Hideki Kobara
Publikováno v:
International Journal of Oncology
Cholangiocarcinoma (CCA) is at an advanced stage at the time of its diagnosis, and developing a more effective treatment of CCA would be desirable. Angiotensin II type 1 (AT1) receptor blocker (ARB), telmisartan may inhibit cancer cell proliferation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a090620fe610a2ea7568e50e35341489
http://europepmc.org/articles/PMC5673010
http://europepmc.org/articles/PMC5673010
Autor:
Joji Tani, Yoshimi Yamana, Hisakazu Iwama, Shintaro Fujihara, Teppei Sakamoto, Takako Nomura, Tomoko Tadokoro, Eri Samukawa, Mitsuomi Hirashima, Koji Fujita, Shima Mimura, Kyoko Oura, Takashi Himoto, Tsutomu Masaki, Hirohito Yoneyama, Asahiro Morishita, Taiga Chiyo, Toshiro Niki
Publikováno v:
International Journal of Oncology. 51:607-614
Liver metastasis from gastrointestinal cancer defines a patient's prognosis. Despite medical developments, pancreatic cancer with liver metastasis confers a very poor prognosis. Galectin-9 (Gal‑9) is a tandem-repeat-type galectin that has recently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36634722e23eafe7be372bcc55c33086
https://doi.org/10.3892/ijo.2017.4053
https://doi.org/10.3892/ijo.2017.4053
Autor:
Noriko Nishiyama, Eri Samukawa, Yoshimi Yamana, Koji Fujita, Hisakazu Iwama, Tae Matsunaga, Maki Ayaki, Tsutomu Masaki, Hirohito Mori, Taiga Chiyo, Hideki Kobara, Asahiro Morishita, Kiyohito Kato, Kyoko Ohura, Shintaro Fujihara, Nobuya Kobayashi, Tatsuo Yachida, Tomoko Tadokoro
Publikováno v:
International Journal of Oncology. 50:2145-2153
Small bowel adenocarcinoma (SBAC) accounts for 3% of all gastrointestinal tract tumors and approximately 0.5% of all cancer cases. Recent studies have indicated that the use of metformin, one of the most commonly prescribed antidiabetic drugs, is ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b1b3e34686ac109d80a59bc7c38be0
https://doi.org/10.3892/ijo.2017.3971
https://doi.org/10.3892/ijo.2017.3971
Autor:
Keiichi Okano, Yasuyuki Suzuki, Koji Fujita, Kyoko Oura, Tsutomu Masaki, Hirohito Mori, Hideki Kobara, Hisakazu Iwama, Teppei Sakamoto, Eri Samukawa, Shintaro Fujihara, Hirohito Yoneyama, Tomoko Tadokoro, Asahiro Morishita, Taiga Chiyo, Yoshimi Yamana, Takako Nomura
Publikováno v:
Oncology Reports
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the third leading cause of cancer-related death. Telmisartan, a widely used antihypertensive drug, is an angiotensin II type 1 (AT1) receptor blocker (ARB) that mig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6d742d3d24afbac74f9d5109b2848e
https://pubmed.ncbi.nlm.nih.gov/29048654
https://pubmed.ncbi.nlm.nih.gov/29048654
Autor:
ERI SAMUKAWA, SHINTARO FUJIHARA, KYOKO OURA, HISAKAZU IWAMA, YOSHIMI YAMANA, TOMOKO TADOKORO, TAIGA CHIYO, KIYOYUKI KOBAYASHI, ASAHIRO MORISHITA, MAI NAKAHARA, HIDEKI KOBARA, HIROHITO MORI, KEIICHI OKANO, YASUYUKI SUZUKI, TAKASHI HIMOTO, TSUTOMU MASAKI
Publikováno v:
International Journal of Oncology; Dec2017, Vol. 51 Issue 6, p1674-1684, 11p
Autor:
KYOKO OURA, TOMOKO TADOKORO, SHINTARO FUJIHARA, ASAHIRO MORISHITA, TAIGA CHIYO, ERI SAMUKAWA, YOSHIMI YAMANA, KOJI FUJITA, TEPPEI SAKAMOTO, TAKAKO NOMURA, HIROHITO YONEYAMA, HIDEKI KOBARA, HIROHITO MORI, HISAKAZU IWAMA, KEIICHI OKANO, YASUYUKI SUZUKI, TSUTOMU MASAKI
Publikováno v:
Oncology Reports; Nov2017, Vol. 38 Issue 5, p2825-2835, 11p
Autor:
TOMOKO TADOKORO, SHINTARO FUJIHARA, TAIGA CHIYO, KYOKO OURA, ERI SAMUKAWA, YOSHIMI YAMANA, KOJI FUJITA, SHIMA MIMURA, TEPPEI SAKAMOTO, TAKAKO NOMURA, JOJI TANI, HIROHITO YONEYAMA, ASAHIRO MORISHITA, TAKASHI HIMOTO, HISAKAZU IWAMA, TOSHIRO NIKI, MITSUOMI HIRASHIMA, TSUTOMU MASAKI
Publikováno v:
International Journal of Oncology; Aug2017, Vol. 51 Issue 2, p607-614, 8p
Autor:
TAIGA CHIYO, KIYOHITO KATO, HISAKAZU IWAMA, SHINTARO FUJIHARA, KOJI FUJITA, TOMOKO TADOKORO, KYOKO OHURA, ERI SAMUKAWA, YOSHIMI YAMANA, NOBUYA KOBAYASHI, TAE MATSUNAGA, NORIKO NISHIYAMA, MAKI AYAKI, TATSUO YACHIDA, ASAHIRO MORISHITA, HIDEKI KOBARA, HIROHITO MORI, TSUTOMU MASAKI
Publikováno v:
International Journal of Oncology; Jun2017, Vol. 50 Issue 6, p2145-2153, 9p